Evidence map›Paper›PMID 37636465›Full record

ArticleHeliyon2023

Carbapenem-resistant gram-negative bacterial prevention practice in nosocomial infection and molecular epidemiological characteristics in a pediatric intensive care unit.

Lijun Yin, Nana Wu, Gangfeng Yan, Lu Lu, Huimin Qian, Weijing Yang, Jian Ma, Leiyan He, Guoping Lu, Xiaowen Zhai and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Lijun YinDepartment of Nosocomial Infection Control, Children's Hospital of Fudan University, Shanghai, China.
Nana WuDepartment of Nosocomial Infection Control, Children's Hospital of Fudan University, Shanghai, China.
Gangfeng YanDepartment of Pediatric Intensive Care Unit, Children's Hospital of Fudan University, Shanghai, China.
Lu LuDepartment of Nosocomial Infection Control, Children's Hospital of Fudan University, Shanghai, China.
Huimin QianDepartment of Nosocomial Infection Control, Children's Hospital of Fudan University, Shanghai, China.
Weijing YangDepartment of Nosocomial Infection Control, Children's Hospital of Fudan University, Shanghai, China.
Jian MaDepartment of Nosocomial Infection Control, Children's Hospital of Fudan University, Shanghai, China.
Leiyan HeThe Clinical Microbiology Laboratory, Children's Hospital of Fudan University, China.
Guoping LuDepartment of Pediatric Intensive Care Unit, Children's Hospital of Fudan University, Shanghai, China.
Xiaowen ZhaiDepartment of Hematology, Children's Hospital of Fudan University, Shanghai, China.
Chuanqing WangDepartment of Nosocomial Infection Control and the Clinical Microbiology Laboratory, Children's Hospital of Fudan University, Shanghai, China.
Children's Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The increasing prevalence of carbapenem-resistant gram-negative bacilli infection has emerged as a substantial threat to human health. Methodology: In January 2017, a screening program for carbapenem-resistant gram-negative bacilli colonization was performed in a pediatric intensive care unit (PICU). Subsequently, different strategies for carbapenem-resistant gram-negative bacilli cohorting and patient placements were introduced in January 2018. Results: The increase in the single room isolation (type A) and the resettlement of the same area placement (type B) resulted in a significant decrease in the nosocomial infection rate from 2.57% (50/1945) in 2017 to 0.87% (15/1720) in 2021 ( Conclusion: The integration of various placements for patients with carbapenem-resistant gram-negative bacilli infection with active screening has been demonstrated as an effective preventive strategy in the management of carbapenem-resistant gram-negative bacilli infection.

Indexed as

Active screeningCarbapenem-resistant gram-negative bacilliKlebsiella pneumoniae carbapenemaseOXA-23Various patient placements

Identifiers

PMID37636465
PMCPMC10448463
OpenAlexW4385605910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.